GUT (GUT) Stock Price & Analysis
GUT (GUT) rose 1.10% to USD 6.43 as of July 25, 2026 at 10:42 UTC, according to Nexqual real-time market data.
GUT last closed at USD 6.36; the session ranged USD 6.38–6.51 on volume of 300,674 shares. Market capitalization is —, with a 52-week range of USD 5.42–7.07 (NYQ). Source: Nexqual, July 25, 2026 at 10:42 UTC.
Key Statistics (as of July 25, 2026 at 10:42 UTC)
| Price | USD 6.43 |
|---|---|
| Change | ▲ 1.10% (up) |
| Previous Close | USD 6.36 |
| Open | USD 6.36 |
| Day Range | USD 6.38 – 6.51 |
| 52-Week Range | USD 5.42 – 7.07 |
| Volume | 300,674 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (GUT)
Nexqual's technical model rates GUT "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 10:42 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 44.78 (neutral) |
| vs SMA50 | Below (USD 6.44) |
| MACD | -0.01 (negative) |
Analyst Ratings (GUT)
Wall Street analysts rate GUT "None", per Nexqual as of July 25, 2026 at 10:42 UTC.
| Consensus Rating | None |
|---|
Earnings (GUT)
Source: Nexqual, July 25, 2026 at 10:42 UTC.
Financials & Fundamentals (GUT)
| Total Revenue | $11.37M |
|---|---|
| Revenue Growth (YoY) | +21.90% |
| Gross Margin | +100.00% |
| Operating Margin | +62.87% |
| Profit Margin | +421.41% |
| ROE | +14.96% |
| Debt / Equity | 0 |
| Current Ratio | 1.06 |
| Total Debt | $5,204 |
| Free Cash Flow | $4.43M |
Source: Nexqual, July 25, 2026 at 10:42 UTC.
Financial Health Score (GUT)
Nexqual rates GUT's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 10:42 UTC.
| Growth | Strong — Revenue +22% YoY (latest Q) |
|---|---|
| Profitability | Weak — Small revenue base — building scale |
| Balance Sheet | Strong — Debt/Equity 0.0x |
| Cash Flow | Strong — FCF $4M, 39% margin |
| Efficiency | Mixed — ROE 15%, ROA 1.4% |
Ownership (GUT)
| Insider Ownership | +1.08% |
|---|---|
| Institutional Ownership | +8.49% |
| Short % of Float | +2.05% |
Source: Nexqual, July 25, 2026 at 10:42 UTC.
Leadership (GUT)
GUT is led by Mario Joseph Gabelli C.F.A. (age 83), Chairman, Chief Investment Officer & Portfolio Manager, per Nexqual as of July 25, 2026 at 10:42 UTC.
| Chairman, Chief Investment Officer & Portfolio Manager | Mario Joseph Gabelli C.F.A. (age 83) |
|---|---|
| Vice President | David I. Schachter (age 72) |
| President, Treasurer, Principal Financial & Accounting Officer | John Chester Ball (age 49) |
| Executive VP & COO | Bruce N. Alpert (age 73) |
Major Backers & Investors (GUT)
Notable institutional backers of GUT include Commonwealth Equity Services, LLC, LPL Financial LLC, Morgan Stanley, according to Nexqual as of July 25, 2026 at 10:42 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Commonwealth Equity Services, LLC | 1.45% |
| LPL Financial LLC | 1.08% |
| Morgan Stanley | 1.05% |
| Cambridge Investment Research Advisors Inc. | 0.68% |
| Osaic Holdings Inc. | 0.54% |
| Gamco Investors, Inc ET AL | 0.38% |
| Plus Group Wealth Advisors LLC | 0.21% |
| Cetera Investment Advisers | 0.2% |
Source: Nexqual, July 25, 2026 at 10:42 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GAB | Gabelli Equity Trust, Inc. (The | USD 5.58 | ▼ 0.36% |
| GGT | Gabelli Multi-Media Trust, Inc. | USD 4.07 | ▼ 0.49% |
| GRX | The Gabelli Healthcare & Wellne | USD 9.56 | ▲ 0.74% |
| GCV | Gabelli Convertible and Income | USD 4.6 | ▼ 1.5% |
| GDV | Gabelli Dividend & Income Trust | USD 29.73 | ▲ 0.37% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 10:42 UTC. This page is informational and not investment advice.